A 52-week International, Multicenter Trial With a Long -Term Extension to Evaluate Saxagliptin With Dapagliflozin in Combination With Metformin Compared to Glimepiride in Combination With Metformin in Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
A 52-week International, Multicenter, Randomized, Double-Blind, Active-Controlled, Parallel Group, Phase 3bTrial With a Blinded 104-week Long -Term Extension Period to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Glimepiride in Combination With Metformin ≥1500 mg in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone
Sponsor: AstraZeneca
A PHASE3 clinical study on Diabetes, this trial is completed. The trial is conducted by AstraZeneca and has accumulated 17 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
17 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jul 2020 — Jan 2021 [monthly]
Completed PHASE3
▶ Show 12 earlier versions
-
Dec 2019 — Jul 2020 [monthly]
Completed PHASE3
-
Nov 2019 — Dec 2019 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
Sep 2019 — Nov 2019 [monthly]
Active Not Recruiting PHASE3
-
Jun 2019 — Sep 2019 [monthly]
Active Not Recruiting PHASE3
-
Feb 2019 — Jun 2019 [monthly]
Active Not Recruiting PHASE3
-
Nov 2018 — Feb 2019 [monthly]
Active Not Recruiting PHASE3
-
Jun 2018 — Nov 2018 [monthly]
Active Not Recruiting PHASE3
-
Oct 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE3
-
Aug 2017 — Oct 2017 [monthly]
Active Not Recruiting PHASE3
-
May 2017 — Aug 2017 [monthly]
Active Not Recruiting PHASE3
-
Feb 2017 — May 2017 [monthly]
Active Not Recruiting PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE3
First recorded
Aug 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- AstraZeneca
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Aguascalientes, Mexico , Ajka, Hungary , Balatonfüred, Hungary , Bialystok, Poland , Birmingham, United States , Brasov, Romania , Bristol, United States , Bucharest, Romania , Budapest, Hungary , Buzău, Romania and 60 more locations